I don't see why big pharma would buy a 'combination' when the the trials for BTX1503 are been conducted without the use of Permetrex, if BTX1503 has patent protection - as the company claims - and the trials are being done by applying the stuff similarly to the way one puts sunscreen on, then why would they be paying for something that wasn't part of the trials?
- Forums
- ASX - By Stock
- BOT
- Ann: Updated Investor Presentation
Ann: Updated Investor Presentation, page-45
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $678.7M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 36.5¢ | $1.170M | 3.137M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 253953 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 972651 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 253953 | 0.370 |
13 | 408818 | 0.365 |
10 | 502187 | 0.360 |
6 | 178811 | 0.355 |
8 | 518350 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 972651 | 23 |
0.385 | 239546 | 8 |
0.390 | 369668 | 20 |
0.395 | 378120 | 10 |
0.400 | 883966 | 24 |
Last trade - 15.35pm 15/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online